Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia

被引:6
|
作者
Li, Jingyu [1 ]
Cai, Ailu [1 ]
Yuan, Qian [1 ]
Ding, Hao [1 ]
Zhao, Dan [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Ultrasound, Shenyang, Liaoning, Peoples R China
关键词
Fetal Doppler; Placental growth factor; Pre-eclampsia; Serum biomarkers; Soluble fms-like tyrosine kinase-1; Uterine artery Doppler; ANGIOGENIC FACTORS; DYSFUNCTION; PREDICTION; MANIFESTATIONS; BIOMARKERS; ULTRASOUND; PREGNANCY; DIAGNOSIS; SFLT-1; ONSET;
D O I
10.1002/ijgo.12796
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To compare serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) concentrations among women with pre-eclampsia and healthy control women and to evaluate the associations of serum PlGF and sFlt-1 with fetal and uterine artery Doppler indices in pre-eclampsia. Methods A prospective cross-sectional study of 33 women with pre-eclampsia and 33 normotensive pregnant women attending a university hospital in China between January and November 2014. Serum PlGF and sFlt-1 were assayed by enzyme linked immunosorbent assays. Doppler indices of the uterine artery, umbilical artery, fetal middle cerebral artery, and ductus venosus were measured. Results The pulsatility index of the uterine artery was negatively correlated with PlGF (r, -0.487; P=0.004) and positively correlated with sFlt-1 (r, 0.420; P=0.015). Gestational age at birth was positively correlated with PlGF (r, 0.601, P<0.001) and negatively correlated with sFlt-1 (r, -0.568; P=0.001). Birth weight was positively correlated with PlGF (r, 0.555; P=0.001) and negatively correlated with sFlt-1 (r, -0.552; P=0.001). Apgar score was negatively correlated with sFlt-1 (r, -0.427; P=0.017). Conclusion Lower PlGF and higher sFlt-1 levels in maternal serum were significantly associated with increased uterine arterial impedance in pre-eclampsia.
引用
收藏
页码:176 / 181
页数:6
相关论文
共 50 条
  • [31] Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia
    Shokry, Mahmoud
    Bedaiwy, Mohamed A.
    Fathalla, Mohamed M. F.
    Alsemary, Ali
    Elwakil, Sahar
    Murphy, Aisling
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2010, 89 (01) : 143 - 146
  • [32] Reference Interval of Soluble FMS-like Tyrosine Kinase-1 in Non-Pregnant and Pregnant Females: A Novel Biomarker for Pre-eclampsia
    Ahmed, Asma Rasheed
    Khan, Muhammad Dilawar
    Batool, Hijab
    Chughtai, Omar
    Chughtai, Akhtar Sohail
    Sarwar, Saman
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (12): : 1395 - 1399
  • [33] Serum soluble FMS-like tyrosine kinase-1 in ectopic pregnancy
    Selvarajan, Sathya
    Ramalingam, Jothimalar
    Vijayaraghavan, Jaya
    Bobby, Zachariah
    JOURNAL OF LABORATORY PHYSICIANS, 2019, 11 (04) : 335 - 339
  • [34] The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application
    Lapaire, Olav
    Shennan, Andrew
    Stepan, Holger
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 151 (02) : 122 - 129
  • [35] Nutraceutical Targeting of Placental Synthesis of Soluble Fms-Like Tyrosine Kinase-1 (sFlt-1) as Strategy for Preventing and Controlling Pre-eclampsia
    Iloki-Assanga, Simon
    McCarty, Mark F.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (20) : 2255 - 2263
  • [36] Prognostic use of soluble fms-like tyrosine kinase-1 and placental growth factor in patients with coronary artery disease
    Sinning, Christoph
    Schnabel, Renate B.
    Zeller, Tanja
    Seiffert, Moritz
    Rupprecht, Hans J.
    Lackner, Karl J.
    Blankenberg, Stefan
    Bickel, Christoph
    Westermann, Dirk
    BIOMARKERS IN MEDICINE, 2016, 10 (01) : 95 - 106
  • [37] Intrauterine growth restriction, soluble fms-like tyrosine kinase-1 to placental growth factor ratio increase and preeclampsia
    Boulanger, H.
    Drouin, D.
    Largilliere, C.
    Lefevre, G.
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2019, 48 (08) : 695 - 697
  • [38] Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction
    Savvidou, Makrina D.
    Yu, Christina K.
    Harland, Lisa C.
    Hingorani, Aroon D.
    Nicolaides, Kypros H.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : 1668 - 1673
  • [39] Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women
    Forest, Jean-Claude
    Theriault, Sebastien
    Masse, Jacques
    Bujold, Emmanuel
    Giguere, Yves
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (08) : 1169 - 1178
  • [40] Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor
    Yue, Cheng Yvonne Kwun
    Yee, Poon Liona Chiu
    Andrew, Shennan
    Yeung, Leung Tak
    Singh, Sahota Daljit
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2019, 17 : 165 - 171